Scarica l'app Stockscreener
53.90
3.87%
-2.17
Dopo l'orario di chiusura:
54.00
0.10
+0.19%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LNTH Giù?
Forum
Previsione
Precedente Chiudi:
$56.07
Aprire:
$55.02
Volume 24 ore:
2.95M
Relative Volume:
2.08
Capitalizzazione di mercato:
$3.66B
Reddito:
$1.50B
Utile/perdita netta:
$427.61M
Rapporto P/E:
8.9684
EPS:
6.01
Flusso di cassa netto:
$423.98M
1 W Prestazione:
-25.79%
1M Prestazione:
-33.71%
6M Prestazione:
-34.35%
1 anno Prestazione:
-44.24%
Intervallo 1D:
$52.75
$55.65
Intervallo di 1 settimana:
$47.25
$57.21
Portata 52W:
$47.25
$118.21
Lantheus Holdings Inc Stock (LNTH) Company Profile
Nome
Lantheus Holdings Inc
Settore
Telefono
978 671-8001
Indirizzo
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Confronta LNTH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
53.90 | 3.81B | 1.50B | 427.61M | 423.98M | 6.01 |
|
ZTS
Zoetis Inc
|
149.77 | 66.04B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.63 | 45.57B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.58 | 42.50B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.60 | 18.84B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
301.39 | 13.59B | 2.99B | 1.21B | 1.13B | 25.06 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-18 | Iniziato | Goldman | Buy |
| 2024-09-03 | Iniziato | Redburn Atlantic | Buy |
| 2024-07-10 | Reiterato | JMP Securities | Mkt Outperform |
| 2023-12-18 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-12-04 | Iniziato | TD Cowen | Outperform |
| 2023-09-29 | Iniziato | William Blair | Outperform |
| 2023-03-08 | Iniziato | JMP Securities | Mkt Outperform |
| 2022-11-30 | Iniziato | SVB Leerink | Outperform |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-05-09 | Iniziato | B. Riley Securities | Buy |
| 2022-04-13 | Iniziato | Truist | Buy |
| 2021-02-01 | Iniziato | SVB Leerink | Outperform |
| 2020-06-29 | Ripresa | Jefferies | Buy |
| 2019-08-16 | Aggiornamento | CJS Securities | Market Perform → Market Outperform |
| 2017-11-02 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2016-11-08 | Reiterato | RBC Capital Mkts | Outperform |
| 2016-09-23 | Ripresa | Credit Suisse | Neutral |
| 2016-02-24 | Reiterato | RBC Capital Mkts | Outperform |
| 2015-12-11 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2015-09-30 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2015-07-20 | Iniziato | Credit Suisse | Outperform |
| 2015-07-20 | Iniziato | Jefferies | Buy |
| 2015-07-20 | Iniziato | RBC Capital Mkts | Outperform |
| 2015-07-20 | Iniziato | Robert W. Baird | Outperform |
| 2015-07-20 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Lantheus Holdings Inc Borsa (LNTH) Ultime notizie
Ongoing Investigation into Lantheus Holdings, Inc. (LNTH): Contact Levi & Korsinsky About Potential Fraud - ACCESS Newswire
Why Lantheus (LNTH) Stock Is Falling Today - Yahoo Finance
Lantheus stock drops as Truist downgrades (LNTH:NASDAQ) - Seeking Alpha
Lantheus Holdings Shares Lower After Truist Securities Downgrade - MarketScreener
This Union Pacific Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga
LNTH ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Lantheus Holdings, Inc. - ACCESS Newswire
LNTH Q2 Deep Dive: Competitive Pressures and Guidance Cut Reshape Lantheus Outlook - Yahoo Finance
Lantheus downgraded to Hold at Truist on Pylarify uncertainty - MSN
Lantheus CCO Amanda Morgan Takes Leave of Absence - TipRanks
Truist Securities downgrades Lantheus stock to Hold on PYLARIFY concerns By Investing.com - Investing.com Canada
LNTH STOCK ALERT: Levi & Korsinsky Notifies Lantheus Holdings, Inc. Investors of an Ongoing Investigation - ACCESS Newswire
Lantheus Holdings (LNTH) Dives 28.6% on Tempered Growth Outlook - MSN
Lantheus lowers 2025 revenue and EPS outlook, targets $1.475B–$1.51B revenue as pricing pressures persist - MSN
Lantheus Holdings, Inc. (NASDAQ:LNTH) Q2 2025 Earnings Call Transcript - Insider Monkey
Lantheus Holdings, Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates - uk.finance.yahoo.com
Lantheus Holdings Inc’s Mixed Earnings Call: Challenges and Strategic Advances - TipRanks
Best Mid Cap Stocks To ResearchAugust 6th - MarketBeat
LNTH: Competition Escalates in PSMA Imaging - Zacks Small Cap Research
Goldman Sachs lowers Lantheus stock price target to $110 on Pylarify concerns - Investing.com Australia
Goldman Sachs lowers Lantheus stock price target to $110 on Pylarify concerns By Investing.com - Investing.com South Africa
Did Lantheus Holdings, Inc. (LNTH) Mislead Investors? Levi & Korsinsky Investigates - ACCESS Newswire
Lantheus Holdings: Mizuho Downgrades to Outperform, PT to $70 from $120. - AInvest
Lantheus (LNTH) shares plummet 33.1% to $48.62. - AInvest
Lantheus Holdings 2025 Q2 Earnings Earnings Surge 26.9% Despite Revenue Dip - AInvest
Lantheus Holdings shares rise 1.79% premarket after announcing a $400 million share repurchase program. - AInvest
Lantheus stock price target lowered to $73 at JMP on pricing pressure - Investing.com Australia
Lantheus Holdings (LNTH) Announces US$400 Million Buyback Amid FDA and Earnings Updates - simplywall.st
Lantheus Holdings Reports Q2 2025 Results and Strategic Moves - TipRanks
Lantheus Shares Tumble 28.58% on $700M Trading Surge to 143rd Rank as FDA Progress and Strategic Moves Unfold - AInvest
Lantheus Holdings shares rise 1.18% after-hours after announcing a $400 million share repurchase program. - AInvest
FDA accepts Lantheus’ NDA for new Pylarify formulation - AuntMinnie
Lantheus Holdings: Q2 Earnings Snapshot - Chron
Lantheus Shares Slide As Earnings And Outlook Fall Short - Finimize
Tranche Update on Lantheus Holdings, Inc.'s Equity Buyback Plan announced on November 20, 2024. - MarketScreener
Lantheus Holdings, Inc. announces an Equity Buyback for $400 million worth of its shares. - MarketScreener
Lantheus Q2 2025 slides: revenue falls 4.1%, company slashes full-year guidance - Investing.com Canada
Lantheus Holdings: Reassessing The Buy Thesis (NASDAQ:LNTH) - Seeking Alpha
Lantheus Holdings stock hits 52-week low at $51.75 By Investing.com - Investing.com Australia
Lantheus Holdings stock hits 52-week low at $51.75 - Investing.com
Earnings call transcript: Lantheus Q2 2025 misses forecasts, shares plunge - Investing.com India
Earnings call transcript: Lantheus Q2 2025 misses forecasts, shares plunge By Investing.com - Investing.com Nigeria
Lantheus Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Lantheus announces FDA review for new radioactive imaging agent - MSN
Lantheus Holdings Inc Q2 2025 Earnings: EPS Surges to $1.12, Bea - GuruFocus
Lantheus Holdings Inc earnings missed by $0.10, revenue fell short of estimates - Investing.com
Lantheus Q2 Adjusted Earnings, Revenue Fall; Lowers 2025 Guidance; Shares Drop Pre-Bell - MarketScreener
Lantheus Holdings Plunges 22.21% on Missed Q2 Earnings - AInvest
Lantheus Announces FDA Acceptance of New Drug Application - TipRanks
Lantheus (NASDAQ:LNTH) Reports Sales Below Analyst Estimates In Q2 Earnings, Stock Drops 20.8% - Yahoo Finance
Lantheus Holdings, Inc. SEC 10-Q Report - TradingView
Why Lantheus Shares Are Taking a Hit - TipRanks
Lantheus Holdings Inc Azioni (LNTH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):